2013 ESMO临床实践指南：成人急性髓性白血病的诊断、治疗与随访 内容预览

该指南为欧洲肿瘤内科学会2013年版的成人急性髓性白血病诊断、治疗与随访指南，指南介绍了成人急性髓性白血病的病因与流行病学、诊断与分子生物学、风险评估与诊断因素、治疗、个体化医疗以及疗效评估与预后。

指南推荐要点：

Diagnostic work-up of AML must in include morphology of pe**heral blood and bone marrow, cytogenetics and molecular genetics assessed before start of therapy

HLA-typing of patient and family members to plan for allogeneic stem cell transplantation where indicated

AML should only be treated in specialised and experienced centres offering a multidisciplinary approach, and the possibility of clinical trials

AML therapy with curative intent includes induction chemotherapy （incorporating an anthracycline and cytarabine）， consolidation which in intermediate to high-risk patients may incorporate allogeneic stem cell transplantation

APL needs a specific therapy approach. ATRA must be started whenever in a case of leukaemia the differential diagnosis of APL is considered, and combined with anthracycline-based chemotherapy once the diagnosis of APL is confirmed

2013 ESMO临床实践指南：成人急性髓性白血病的诊断、治疗与随访陈文明完整版下载地址：http://ziyuan.iiyi.com/source/down/2321399.html